{"organizations": [], "uuid": "88722ccdc77c5b11e4589600cd15fe12c6c0935c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180214.html", "section_title": "Archive News &amp; Video for Wednesday, 14 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-reg-dbv-technologies-provides-upda/brief-reg-dbv-technologies-provides-update-on-regulatory-progress-for-viaskin-peanut-idUSFWN1Q31GN", "country": "US", "domain_rank": 408, "title": "BRIEF-Reg-Dbv Technologies Provides Update On Regulatory Progress For Viaskin Peanut", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.435, "site_type": "news", "published": "2018-02-14T14:36:00.000+02:00", "replies_count": 0, "uuid": "88722ccdc77c5b11e4589600cd15fe12c6c0935c"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-reg-dbv-technologies-provides-upda/brief-reg-dbv-technologies-provides-update-on-regulatory-progress-for-viaskin-peanut-idUSFWN1Q31GN", "ord_in_thread": 0, "title": "BRIEF-Reg-Dbv Technologies Provides Update On Regulatory Progress For Viaskin Peanut", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "brief-reg-dbv technologies provides update on regulatory progress for viaskin peanut", "sentiment": "negative"}, {"name": "fda", "sentiment": "none"}, {"name": "bla", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "viaskin", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 14 (Reuters) - Dbv Technologies Sa:\n* REG-DBV TECHNOLOGIES PROVIDES UPDATE ON REGULATORY PROGRESS FOR VIASKIN PEANUT\n* FDA AGREED TO SUBMISSION OF A BIOLOGICS LICENSE APPLICATION (BLA) FOR TREATMENT OF PEANUT ALLERGY IN CHILDREN AGED 4 TO 11\n* DBV REMAINS ON TRACK TO SUBMIT ITS BLA IN SECOND HALF OF 2018. Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-14T14:36:00.000+02:00", "crawled": "2018-02-15T20:48:37.020+02:00", "highlightTitle": ""}